| Morepen Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.06 | 0.03 | 0.03 | 0.03 | 0.21 |
| Long Term Debt-Equity Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.23 | 2.38 | 1.99 | 1.49 | 1.19 |
| Fixed Assets | 2.76 | 3.11 | 2.70 | 2.91 | 1.92 |
| Inventory | 6.14 | 7.13 | 5.70 | 6.77 | 7.37 |
| Debtors | 5.09 | 5.37 | 5.61 | 7.68 | 8.03 |
| Interest Cover Ratio | 20.38 | 43.44 | 32.84 | -16.03 | 53.65 |
| PBIDTM (%) | 10.88 | 11.34 | 6.20 | 9.62 | 11.16 |
| PBITM (%) | 9.31 | 9.92 | 4.86 | 8.15 | 8.63 |
| PBDTM (%) | 10.42 | 11.11 | 6.05 | 10.13 | 11.00 |
| CPM (%) | 8.11 | 8.64 | 4.80 | 8.44 | 11.00 |
| APATM (%) | 6.53 | 7.22 | 3.45 | 6.97 | 8.47 |
| ROCE (%) | 12.79 | 17.08 | 8.78 | 20.85 | 19.57 |
| RONW (%) | 9.81 | 13.29 | 6.71 | 19.38 | 24.43 |